These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 6846113

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prostacyclin prevents ventricular fibrillation in a canine model of sudden cardiac death.
    Fiedler VB, Mardin M.
    Basic Res Cardiol; 1986; 81(1):40-53. PubMed ID: 3521579
    [Abstract] [Full Text] [Related]

  • 3. Prevention of chronic canine ventricular tachyarrhythmias with bretylium tosylate.
    Patterson E, Gibson JK.
    Circulation; 1981 Nov; 64(5):1045-50. PubMed ID: 7285294
    [Abstract] [Full Text] [Related]

  • 4. A method for quantitating antifibrillatory effects of drugs after coronary reperfusion in dogs: improved outcome with bretylium.
    Wenger TL, Lederman S, Starmer CF, Brown T, Strauss HC.
    Circulation; 1984 Jan; 69(1):142-8. PubMed ID: 6689638
    [Abstract] [Full Text] [Related]

  • 5. Experimental and clinical pharmacology of bretylium tosylate in acute myocardial infarction: a 15-year journey.
    Puddu PE, Jouve R, Saadjian A, Torresani J.
    J Pharmacol; 1986 Jan; 17(3):223-43. PubMed ID: 3795968
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ventricular fibrillation in a conscious canine model--its prevention by UM-272.
    Eller BT, Patterson E, Lucchesi BR.
    Eur J Pharmacol; 1983 Mar 04; 87(4):407-13. PubMed ID: 6852097
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the ischemic feline heart.
    Kowey PR, Friehling TD, O'Connor KM, Wetstein L, Kelliher GJ.
    Am Heart J; 1985 Aug 04; 110(2):363-70. PubMed ID: 4025111
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of bretylium tosylate on the in vivo fibrillating canine ventricle.
    Breznock EM, Kagan K, Hibser NK.
    Am J Vet Res; 1977 Jan 04; 38(1):89-94. PubMed ID: 835872
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. HBI-3000 prevents secondary sudden cardiac death.
    Lee JY, Lucchesi BR.
    J Cardiovasc Pharmacol Ther; 2013 Sep 04; 18(5):453-9. PubMed ID: 23615576
    [Abstract] [Full Text] [Related]

  • 20. Anesthetized rabbit as a model for ischemia- and reperfusion-induced arrhythmias: effects of quinidine and bretylium.
    Coker SJ.
    J Pharmacol Methods; 1989 Jul 04; 21(4):263-79. PubMed ID: 2755145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.